Pacific Biosciences of California, Inc. Profile Avatar - Palmy Investing

Pacific Biosciences of California, Inc.

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumabl…
Medical - Devices
US, Menlo Park [HQ]

Cash Flow Statement

15 Sheets · From 2023 to 2009
Configuration
In Million USD. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Operating Activities
Operating Cash Flow (OCF)
-74.00 -121.00 -102.00 -76.00 -29.00 -51.00 -47.00 -67.00 -67.00 -66.00 -78.00 19.00 -111.00 -263.00 -266.00
Operating Cash (Net)
-74.00 -121.00 -102.00 -76.00 -29.00 -51.00 -47.00 -67.00 -67.00 -66.00 -78.00 19.00 -111.00 -263.00 -266.00
Accounts Receivable
- - - - -4.00 1.00 - - - - -1.00 -6.00 -2.00 4.00 -6.00 -1.00 -7.00 5.00 -17.00
Accounts Payable
3.00 3.00 -4.00 -1.00 -1.00 3.00 - - 3.00 - - -2.00 1.00 - - 14.00 1.00 - -
Working Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Investing Activities
Used Cash (Net)
18.00 -138.00 6.00 61.00 -33.00 19.00 8.00 -14.00 -1.00 -38.00 62.00 -219.00 -678.00 116.00 4.00
Capital Expenditure
-5.00 -5.00 -9.00 -1.00 - - -1.00 -3.00 -8.00 -10.00 -1.00 -2.00 -1.00 -5.00 -16.00 -8.00
Purchases of Investments
-25.00 -180.00 -264.00 -87.00 -201.00 -126.00 -84.00 -95.00 -86.00 -122.00 -57.00 -373.00 -988.00 -442.00 -756.00
Sale/Maturity of Investment
49.00 47.00 279.00 151.00 169.00 147.00 100.00 89.00 95.00 85.00 122.00 155.00 635.00 575.00 770.00
Property, Plant, Equipment (P&PE)
-5.00 -5.00 -9.00 -1.00 - - -1.00 -3.00 -8.00 -10.00 -1.00 -2.00 -1.00 -5.00 -16.00 -8.00
Acquisitions (Net)
- - - - - - -61.00 - - - - - - - - - - - - -64.00 218.00 -319.00 - - - -
Other Investing Activities
- - - - - - 61.00 - - - - -4.00 - - - - - - 64.00 -218.00 -352.00 - - 13.00
Financing Activities
Used Cash (Net)
-67.00 -318.00 -7.00 -2.00 -42.00 -41.00 -36.00 -65.00 -68.00 -107.00 -26.00 -251.00 -1,169.00 -9.00 -116.00
Debt Repayment
-1.00 - - - - - - -19.00 - - - - - - -4.00 - - - - -16.00 -895.00 -1.00 -1.00
Dividends Paid
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Common Stock
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Financing Activities
68.00 107.00 - - - - 23.00 3.00 7.00 65.00 8.00 9.00 18.00 80.00 -52.00 11.00 -86.00
Cash Balances
Begin of Period
78.00 89.00 147.00 58.00 46.00 26.00 36.00 33.00 16.00 21.00 23.00 33.00 85.00 465.00 325.00
End of Period
89.00 147.00 58.00 46.00 26.00 36.00 33.00 16.00 16.00 23.00 33.00 85.00 465.00 328.00 180.00
Change
10.00 58.00 -88.00 -12.00 -20.00 10.00 -2.00 -16.00 - - 2.00 10.00 52.00 379.00 -137.00 -145.00
Non-Cash Balances
Depreciation and Amortization
4.00 5.00 5.00 6.00 5.00 4.00 3.00 3.00 8.00 7.00 9.00 9.00 11.00 17.00 32.00
Stock Based Compensation
3.00 9.00 12.00 9.00 9.00 9.00 13.00 19.00 20.00 23.00 16.00 17.00 73.00 78.00 72.00
Other
- - - - - - - - - - 1.00 -2.00 1.00 1.00 1.00 -16.00 -33.00 57.00 9.00 5.00
Highlighted metrics
Free Cash Flow (FCF)
-80.00 -127.00 -112.00 -78.00 -30.00 -53.00 -50.00 -76.00 -77.00 -68.00 -81.00 18.00 -117.00 -280.00 -275.00
Cash Conversion Cycle (CCC)
- - - - 237.00 135.00 175.00 76.00 78.00 102.00 139.00 115.00 93.00 161.00 137.00 230.00 161.00
Invested Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Operating Inflows/Outflows